Optmed

NEW YORK, Sept. 12, 2017 /PRNewswire/ -- OptMed, Inc., a medical device company focused on the commercialization of BondEase®, a novel surgical adhesive, announced today that it formed a strategic relationship with Synecoun, a Chinese medical technology company located in China Medical City, Taizhou, a major biopharmaceutical Chinese hub. Synecoun is positioned with a unique focus [...]

NEW YORK (December 17, 2012)--- OptMed Inc., a specialty healthcare product development company, announced the completion of its required 30 patient enrollment for the first phase of a multicenter, prospective, open-label, randomized clinical study to evaluate BondEaseTM Topical Skin Adhesive.